Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
B-1 cells produce natural Abs which provide an integral first line of defense against pathogens while also performing important homeostatic housekeeping functions. In this study, we demonstrate that
programmed cell death 1 ligand 2
(
PD-L2
) regulates the production of natural Abs against phosphorylcholine (PC). Naive
PD-L2
-deficient (
PD-L2
-/-
) mice produced significantly more PC-reactive IgM and IgA. This afforded
PD-L2
-/-
mice with selectively enhanced protection against PC-expressing nontypeable
Haemophilus
influenzae
, but not PC-negative nontypeable
Haemophilus
influenzae
, relative to wild-type mice.
PD-L2
-/-
mice had significantly increased PC-specific CD138
+
splenic plasmablasts bearing a B-1a phenotype, and produced PC-reactive Abs largely of the T15 Id. Importantly, PC-reactive B-1 cells expressed
PD-L2
and irradiated chimeras demonstrated that B cell-intrinsic
PD-L2
expression regulated PC-specific Ab production. In addition to increased PC-specific IgM, naive
PD-L2
-/-
mice and irradiated chimeras reconstituted with
PD-L2
-/-
B cells had significantly higher levels of IL-5, a potent stimulator of B-1 cell Ab production.
PD-L2
mAb blockade of wild-type B-1 cells in culture significantly increased CD138 and Blimp1 expression and PC-specific IgM, but did not affect proliferation.
PD-L2
mAb blockade significantly increased IL-5
+
T cells in culture. Both IL-5 neutralization and STAT5 inhibition blunted the effects of
PD-L2
mAb blockade on B-1 cells. Thus, B-1 cell-intrinsic
PD-L2
expression inhibits IL-5 production by T cells and thereby limits natural Ab production by B-1 cells. These findings have broad implications for the development of therapeutic strategies aimed at altering natural Ab levels critical for protection against infectious disease, autoimmunity, allergy, cancer, and atherosclerosis.
...
PMID:PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism. 2876 24